One target gene of HNF4A is galectin 4, which was described as tumor-suppressor in colon cancer [52,53], but also pancreatic duct adenocarcinoma [54], and was accordingly positively associated with high CDX1 mRNA expression in the current study. This evidence concerns the gene HNF4A and neoplasm.